LONDON BROKER RATINGS: Citi and Jefferies say buy Astra after tumble
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More
| Price | 161.60p on 16-07-2026 at 15:00:02 |
|---|---|
| Change | 3.40p 2.15% |
| Buy | 161.80p |
| Sell | 161.40p |
| Last Trade: | Buy 1,352.00 at 161.80p |
| Day's Volume: | 384,386 |
| Last Close: | 158.20p |
| Open: | 158.60p |
| ISIN: | GB0002418548 |
| Day's Range | 158.20p - 161.60p |
| 52wk Range: | 136.00p - 179.60p |
| Market Capitalisation: | £920.66m |
| VWAP: | 160.23779p |
| Shares in Issue: | 569.71m |
Elementis (ELM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 1,352 | 161.80p | SI Trade |
16:00:00 - 16-Jul-26 |
| Buy* | 800 | 161.60p | Automatic Execution |
15:56:16 - 16-Jul-26 |
| Buy* | 750 | 161.60p | Automatic Execution |
15:56:16 - 16-Jul-26 |
| Sell* | 1 | 161.40p | Ordinary |
15:55:21 - 16-Jul-26 |
| Buy* | 200 | 161.40p | Automatic Execution |
15:51:58 - 16-Jul-26 |
| Buy* | 356 | 161.40p | Automatic Execution |
15:51:58 - 16-Jul-26 |
| Buy* | 296 | 161.40p | Automatic Execution |
15:51:58 - 16-Jul-26 |
| Buy* | 830 | 161.40p | Automatic Execution |
15:51:58 - 16-Jul-26 |
| Buy* | 1,231 | 161.40p | Automatic Execution |
15:51:58 - 16-Jul-26 |
| Sell* | 974 | 161.20p | Automatic Execution |
15:50:17 - 16-Jul-26 |
Elementis (ELM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 13th Jul 2026 5:45 pm | RNS | Transaction in Own Shares |
| 6th Jul 2026 5:24 pm | RNS | Transaction in Own Shares |
| 1st Jul 2026 6:26 pm | RNS | Total Voting Rights |
| 29th Jun 2026 6:11 pm | RNS | Transaction in Own Shares |
| 22nd Jun 2026 2:42 pm | RNS | Transaction in Own Shares |
| 22nd Jun 2026 2:30 pm | RNS | Transaction in Own Shares |
| 15th Jun 2026 12:42 pm | RNS | Transaction in Own Shares |
| 8th Jun 2026 5:14 pm | RNS | Transaction in Own Shares |
| 3rd Jun 2026 7:00 am | RNS | Commencement of share buyback programme |
| 2nd Jun 2026 7:00 am | RNS | Sale of Pharma business & intended buyback launch |